Market News Archive
Stay updated with the latest announcements
HRTEX: Q1 Financials (Additional Information)
(Q1 Un-audited): Reasons for deviation: EPS has been decreased due to lack of sufficient export order. NOCFPS has been decreased due to lack of sufficient export order and payment and receivable mismatch.
STANCERAM: Q1 Financials
(Q1 Un-audited): EPS was Tk. (7.14) for July-September 2024 as against Tk. (7.34) for July-September 2023; NOCFPS was Tk. (0.20) for July-September 2024 as against Tk. (8.16) for July-September 2023. NAV per share was Tk. (44.98) as on September 30, 2024 and Tk. (37.84) as on June 30, 2024. (cont.)
HRTEX: Q1 Financials
(Q1 Un-audited): EPS was Tk. (2.82) for July-September 2024 as against Tk. 0.94 for July-September 2023. NOCFPS was Tk. (2.72) for July-September 2024 as against Tk. 2.83 for July-September 2023. NAV per share was Tk. 18.61 as on September 30, 2024 and Tk. 21.43 as on June 30, 2024.
SKTRIMS: Q1 Financials (Additional Information)
Reasons for deviation: The EPS of the company from 1st July 2024 to 30 September 2024 is negative because of export revenue has decreased vastly as well as manufacturing cost, operating expenses and finance cost of the company has increased that's why Net Profit after Tax of the company has decreased compared to Sep 30, 2023. (cont.)
SKTRIMS: Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.53) for July-September 2024 as against Tk. 0.51 for July-September 2023; NOCFPS was Tk. (0.02) for July-September 2024 as against Tk. 0.55 for July-September 2023. NAV per share was Tk. 14.96 as on September 30, 2024 and Tk. 15.95 as on September 30, 2023.
BIFC: Q3 Financials
(Q3 Un-audited): EPS was Tk. (1.06) for July-September 2024 as against Tk. (1.06) for July-September 2023; EPS was Tk. (2.61) for January-September 2024 as against Tk. (3.44) for January-September 2023. NOCFPS was Tk. 0.12 for January-September 2024 as against Tk. (3.09) for January-September 2023. NAV per share was Tk. (122.06) as on September 30, 2024 and Tk. (117.85) as on September 30, 2023.
BIFC: Q2 Financials
(Q2 Un-audited): EPS was Tk. (0.61) for April-June 2024 as against Tk. (0.90) for April-June 2023. EPS was Tk. (1.55) for January-June 2024 as against Tk. (2.37) for January-June 2023. NOCFPS was Tk. 0.26 for January-June 2024 as against Tk. (2.20) for January-June 2023. NAV per share was Tk. (121.00) as on June 30, 2024 and Tk. (116.79) as on June 30, 2023.
DACCADYE: Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.44) for July-September 2024 as against Tk. (0.42) for July-September 2023; NOCFPS was Tk. 0.23 for July-September 2024 as against Tk. 0.40 for July-September 2023. NAV per share was Tk. 31.10 as on September 30, 2024 and Tk. 31.51 as on June 30, 2024.
BIFC: Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.94) for January-March 2024 as against Tk. (1.47) for January-March 2023. NOCFPS was Tk. (0.06) for January-March 2024 as against Tk. (1.20) for January-March 2023. NAV per share was Tk. (120.39) as on March 31, 2024 and Tk. (115.89) as on March 31, 2023.
SUMITPOWER: BSEC's consent for extension of financial statement submission
The company has informed that the Bangladesh Securities and Exchange Commission (BSEC) has given consent to extend the time for submission of audited financial statements for the year ended on 30 June 2024 (against the scheduled date of 28 October 2024), first quarterly un-audited financial statements for the period ended on 30 September 2024 (against the scheduled date of 14 November 2024) and second quarterly un-audited financial statements for the period ending on (cont.)
LIBRAINFU: High Court Directive to ensure financial support for Libra Infusions
The company has informed that the Honorable High Court has issued a Rule Nisi instructing Al-Arafah Islami Bank PLC. to provide all forms of financial assistance to Libra Infusions Limited in accordance with the agreement executed between them. As a result of this directive, there will no longer be any shortfall in the working capital of Libra Infusions Limited. Consequently, there are no longer any obstacle to full-scale production.
PLFSL: Q3 Financials (Additional Information)
EPS was Tk. (4.17) for July-September 2024 as against Tk. (3.71) for July-September 2023; EPS was Tk. (9.90) for January-September 2024 as against Tk. (9.66) for January-September 2023. NOCFPS was Tk. (0.07) for January-September 2024 as against Tk. 0.23 for January-September 2023. The previously disseminated news with the same figure has been disseminated again to specify the period.
PLFSL: Q2 Financials (Additional Information)
EPS was Tk. (2.76) for April-June 2024 as against Tk. (2.96) for April-June 2023; EPS was Tk. (5.74) for January-June 2024 as against Tk. (5.92) for January-June 2023. NOCFPS was Tk. 0.36 for January-June 2024 as against Tk. 0.24 for January-June 2023. The previously disseminated news with the same figure has been disseminated again to specify the period.
PLFSL: Q1 Financials (Additional Information)
EPS was Tk. (2.98) for January-March 2024 as against Tk. (2.96) for January-March 2023. NOCFPS was Tk. 0.30 for January-March 2024 as against Tk. 0.09 for January-March 2023. The previously disseminated news with the same figure has been disseminated again to specify the period.
PLFSL: Q3 Financials
(Q3 Un-audited): EPS was Tk. (9.90), NOCFPS was Tk. (0.07) and NAV per share was Tk. (145.60) as on September 30, 2024 as against Tk. (9.66), Tk. 0.23 and Tk. (134.22) as on September 30, 2023.
PLFSL: Q2 Financials
(Q2 Un-audited): EPS was Tk. (5.74), NOCFPS was Tk. 0.36 and NAV per share was Tk. (141.43) as on June 30, 2024 as against Tk. (5.92), Tk. 0.24 and Tk. (130.50) as on June 30, 2023.
PLFSL: Q1 Financials
(Q1 Un-audited): EPS was Tk. (2.98), NOCFPS was Tk. 0.30 and NAV per share was Tk. (138.68) as on March 31, 2024 as against Tk. (2.96), Tk. 0.09 and Tk. (127.09) as on March 31, 2023.
IBP: Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.03) for July-September 2024 as against Tk. 0.01 for July-September 2023; NOCFPS was Tk. (0.06) for July-September 2024 as against Tk. 0.09 for July-September 2023. NAV per share was Tk. 13.58 as on September 30, 2024 and Tk. 13.60 as on June 30, 2024. Reasons for Significant Deviation: (cont.1)
EPGL: Q1 Financials (Additional Information)
(Q1 Un-audited): Reasons for deviation in EPS: The reason for the decrease in EPS is due to incurring a huge finance charge than last year and hike in interest rates.
EPGL: Q1 Financials
(Q1 Un-audited): EPS was Tk. (1.85) for July-September 2024 as against Tk. 0.05 for July-September 2023; NOCFPS was Tk. 0.22 for July-September 2024 as against Tk. 0.01 for July-September 2023. NAV per share (with revaluation) was Tk. 35.54 as on September 30, 2024 and Tk. 37.45 as on June 30, 2024. NAV per share (without revaluation) was Tk. 23.64 as on September 30, 2024 and Tk. 25.55 as on June 30, 2024.